Baxter Recalls One Lot of Anticoagulant Sodium Citrate Solution Over Potential Particulate Matter

Baxter International Inc. recently announced a voluntary nationwide recall of one lot of anticoagulant sodium citrate solution due to the potential presence of particulate matter identified as fiberglass.

The affected product is packaged in 250 mL Viaflex plastic containers and is intended for use only with automated apheresis devices. It is not intended for direct intravenous infusion. The recall applies to lot Y493475, which has an expiration date of Dec. 31, 2027. The lot was distributed to one U.S. customer between July 2 and July 11, 2026.

According to Baxter, administration of solution containing particulate matter may cause local vein irritation, inflammatory or hypersensitivity reactions or systemic embolization that could result in tissue or organ injury. The extent and severity of potential harm depend on the characteristics of the particulate material. Baxter noted that the absence of in-line filtration increases the risk.

As of Aug. 25, Baxter had not received reports of adverse events associated with the recalled product. The company is contacting the affected customer by email with instructions for identifying and returning the recalled units and advised the customer to discontinue use immediately.